CD40 and inflammatory breast carcinoma: Three genes encoding immune markers were associated with hypermethylated DMRs (CD40 promoter, and CD8A and MMP9 gene bodies), and three were associated with hypomethylated DMRs (CD1B gene body, FCER1A promoter, and TIGIT promoter/gene body) in IBC.